Myxoid Liposarcoma Clinical Trial
Official title:
International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01957709 -
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
|
Early Phase 1 | |
Active, not recruiting |
NCT03600649 -
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
|
Phase 1 | |
Completed |
NCT02821507 -
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
|
Phase 2 | |
Withdrawn |
NCT03397186 -
Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
|
Phase 2 | |
Active, not recruiting |
NCT03989596 -
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
|
Phase 2 | |
Enrolling by invitation |
NCT05266196 -
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
|
Phase 1/Phase 2 | |
Recruiting |
NCT05492682 -
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
|
Phase 1 | |
Active, not recruiting |
NCT03651375 -
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
|
Phase 2 | |
Active, not recruiting |
NCT00633165 -
Brostallicin Clinical Trial for Myxoid Liposarcoma
|
Phase 2 | |
Recruiting |
NCT04044768 -
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
|
Phase 2 | |
Active, not recruiting |
NCT03816475 -
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)
|
Phase 2 |